Schedule 13D ownership disclosure

EUPRAXIA PHARMACEUTICALS INC

Common Shares · CUSIP: 29842P105

Event date: 2025-09-24

Filing-level shares
5,533,215
Percent of class
10.2%
  • Joseph S. FreedmanReported CIK 0002043590

    Shares: 5,533,215 · Class: 10.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-25-001145
Form type
SCHEDULE 13D/A
Filer
EUPRAXIA PHARMACEUTICALS INC.
CIK
CIK 1581178
Filed
Sep 26, 2025
Reporting period
Sep 24, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub